Vaxxas, a clinical-stage biotechnology company, today announced it has completed enrollment for its Phase I clinical trial of a vaccine against an avian influenza A (H7N9) virus with pandemic ...
Overwatch Capital is proud to announce the acquisition of a premier ±150,000-square-foot data center facility located in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback